ACM
Aquatic Capital Management Portfolio holdings
AUM
$4.95B
1-Year Return
14.13%
This Quarter Return
-6.66%
1 Year Return
+14.13%
3 Year Return
+25.42%
5 Year Return
–
10 Year Return
–
AUM
$66.9M
AUM Growth
+$15.1M
(+29%)
Cap. Flow
+$17.9M
Cap. Flow
% of AUM
26.75%
Top 10 Holdings %
Top 10 Hldgs %
20.14%
Holding
1,675
New
574
Increased
179
Reduced
264
Closed
625
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$2.12M |
| 2 |
Lowe's Companies
LOW
|
+$1.8M |
| 3 |
Coca-Cola
KO
|
+$1.46M |
| 4 |
UnitedHealth
UNH
|
+$1.22M |
| 5 |
Illinois Tool Works
ITW
|
+$963K |
Top Sells
| 1 |
Sea Limited
SE
|
+$626K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$579K |
| 3 |
Goldman Sachs
GS
|
+$421K |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$420K |
| 5 |
Thermo Fisher Scientific
TMO
|
+$400K |
Sector Composition
| 1 | Financials | 18.67% |
| 2 | Industrials | 18.23% |
| 3 | Technology | 15.98% |
| 4 | Healthcare | 12.98% |
| 5 | Consumer Discretionary | 12.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Marten Transport
MRTN
$975M
| $2K | ﹤0.01% |
100
| – | – |
|
952
Acco Brands
ACCO
$372M
| $2K | ﹤0.01% |
+200
| New | +$2K |
|
953
American Coastal Insurance
ACIC
$539M
| $2K | ﹤0.01% |
+500
| New | +$2K |
|
954
Aurinia Pharmaceuticals
AUPH
$1.68B
| $2K | ﹤0.01% |
+200
| New | +$2K |
|
|
AXDX
955
DELISTED
Accelerate Diagnostics
AXDX
| $2K | ﹤0.01% |
160
-170
| -52% | -$2.13K |
|
956
Banco de Chile
BCH
$15.6B
| $2K | ﹤0.01% |
100
-1,000
| -91% | -$20K |
|
957
Berry Corp
BRY
$255M
| $2K | ﹤0.01% |
200
-100
| -33% | -$1K |
|
958
Cadiz
CDZI
$312M
| $2K | ﹤0.01% |
900
-3,500
| -80% | -$7.78K |
|
959
Cardiff Oncology
CRDF
$138M
| $2K | ﹤0.01% |
700
-7,300
| -91% | -$20.9K |
|
960
Gladstone Investment Corp
GAIN
$547M
| $2K | ﹤0.01% |
100
| – | – |
|
961
Horizon Bancorp
HBNC
$842M
| $2K | ﹤0.01% |
+100
| New | +$2K |
|
962
HUTCHMED
HCM
$2.81B
| $2K | ﹤0.01% |
100
-4,700
| -98% | -$94K |
|
963
Independent Bank Corp
IBCP
$666M
| $2K | ﹤0.01% |
+100
| New | +$2K |
|
964
ImmunityBio
IBRX
$2.45B
| $2K | ﹤0.01% |
+400
| New | +$2K |
|
965
Immersion
IMMR
$221M
| $2K | ﹤0.01% |
300
-3,100
| -91% | -$20.7K |
|
966
Inseego
INSG
$208M
| $2K | ﹤0.01% |
+40
| New | +$2K |
|
967
KALA BIO
KALA
$119M
| $2K | ﹤0.01% |
24
-100
| -81% | -$8.33K |
|
968
Korea Electric Power
KEP
$17.6B
| $2K | ﹤0.01% |
200
| – | – |
|
969
Kiniksa Pharmaceuticals
KNSA
$2.74B
| $2K | ﹤0.01% |
+200
| New | +$2K |
|
970
Kodiak Sciences
KOD
$524M
| $2K | ﹤0.01% |
200
-100
| -33% | -$1K |
|
971
Laureate Education
LAUR
$4.28B
| $2K | ﹤0.01% |
200
-4,800
| -96% | -$48K |
|
972
Luxfer Holdings
LXFR
$369M
| $2K | ﹤0.01% |
+100
| New | +$2K |
|
973
Marcus Corp
MCS
$503M
| $2K | ﹤0.01% |
+100
| New | +$2K |
|
974
NeoGenomics
NEO
$1.08B
| $2K | ﹤0.01% |
+200
| New | +$2K |
|
975
NMI Holdings
NMIH
$3.13B
| $2K | ﹤0.01% |
+100
| New | +$2K |
|